V. Christoffels, H. Sassi, J. Ruijter, A. Moorman, T. Grange et al., A mechanistic model for the development and maintenance of portocentral gradients in gene expression in the liver, Hepatology, vol.84, issue.4, pp.1180-1192, 1999.
DOI : 10.1002/hep.510290413

R. Gebhardt, Metabolic zonation of the liver: Regulation and implications for liver function, Pharmacology & Therapeutics, vol.53, issue.3, pp.275-354, 1992.
DOI : 10.1016/0163-7258(92)90055-5

K. Jungermann and N. Katz, Functional specialization of different hepatocyte populations, Physiol Rev, vol.69, issue.3, pp.708-764, 1989.

K. Jungermann and T. Kietzmann, Zonation of Parenchymal and Nonparenchymal Metabolism in Liver, Annual Review of Nutrition, vol.16, issue.1, pp.179-203, 1996.
DOI : 10.1146/annurev.nu.16.070196.001143

A. Braeuning and M. Schwarz, ??-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver, Biological Chemistry, vol.391, issue.2/3, pp.139-148, 2009.
DOI : 10.1515/bc.2010.012

S. Sheikh-bahaei, J. Maher, A. Hunt, and C. , Computational experiments reveal plausible mechanisms for changing patterns of hepatic zonation of xenobiotic clearance and hepatotoxicity, Journal of Theoretical Biology, vol.265, issue.4, pp.718-733, 2010.
DOI : 10.1016/j.jtbi.2010.06.011

M. Ierapetritou, P. Georgopoulos, C. Roth, and L. Androulakis, Tissue-Level Modeling of Xenobiotic Metabolism in Liver: An Emerging Tool for Enabling Clinical Translational Research, Clinical and Translational Science, vol.27, issue.4, pp.228-237, 2009.
DOI : 10.1111/j.1752-8062.2009.00092.x

S. Thorgeirsson and J. Grisham, Molecular pathogenesis of human hepatocellular carcinoma, Nature Genetics, vol.31, issue.4, pp.339-346, 2002.
DOI : 10.1038/ng0802-339

L. Roberts and G. Gores, Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis, pp.212-225, 2005.

S. Benhamouche, T. Decaens, C. Godard, R. Chambrey, D. Rickman et al., Apc Tumor Suppressor Gene Is the ???Zonation-Keeper??? of Mouse Liver, Developmental Cell, vol.10, issue.6, pp.759-770, 2006.
DOI : 10.1016/j.devcel.2006.03.015

A. Moriyama, I. Kii, T. Sunabori, S. Kurihara, I. Takayama et al., GFP transgenic mice reveal active canonical Wnt signal in neonatal brain and in adult liver and spleen, genesis, vol.16, issue.2, pp.4590-100, 2007.
DOI : 10.1002/dvg.20268

M. Glickman and A. Ciechanover, The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction, Physiological Reviews, vol.82, issue.2, pp.373-428, 2002.
DOI : 10.1152/physrev.00027.2001

C. Joazeiro, S. Wing, H. Huang, J. Leverson, T. Hunter et al., The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase, Science, vol.286, issue.5438, pp.309-312, 1999.
DOI : 10.1126/science.286.5438.309

W. Huangfu and S. Fuchs, Ubiquitination-Dependent Regulation of Signaling Receptors in Cancer, Genes & Cancer, vol.1, issue.7, pp.725-734
DOI : 10.1177/1947601910382901

A. Burger and A. Seth, The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications, European Journal of Cancer, vol.40, issue.15, pp.2217-2229, 2004.
DOI : 10.1016/j.ejca.2004.07.006

V. Mootha, C. Lindgren, K. Eriksson, A. Subramanian, S. Sihag et al., PGC-1??-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nature Genetics, vol.34, issue.3, pp.267-273, 2003.
DOI : 10.1038/ng1180

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.10215545-15550, 2005.
DOI : 10.1073/pnas.0506580102

R. Thomas, J. Gohlke, G. Stopper, F. Parham, and C. Portier, Choosing the right path: enhancement of biologically relevant sets of genes or proteins using pathway structure, Genome Biology, vol.10, issue.4, p.44, 2009.
DOI : 10.1186/gb-2009-10-4-r44

C. Guguen-guillouzo and A. Guillouzo, General Review on In Vitro Hepatocyte Models and Their Applications, Methods Mol Biol, vol.640, pp.1-40, 2010.
DOI : 10.1007/978-1-60761-688-7_1
URL : https://hal.archives-ouvertes.fr/hal-00742202

T. Vanhaecke and V. Rogiers, Hepatocyte Cultures in Drug Metabolism and Toxicological Research and Testing, Methods Mol Biol, vol.320, pp.209-227, 2006.
DOI : 10.1385/1-59259-998-2:209

L. Griffith and G. Naughton, Tissue Engineering--Current Challenges and Expanding Opportunities, Science, vol.295, issue.5557, pp.1009-1014, 2002.
DOI : 10.1126/science.1069210

R. Baudoin, A. Corlu, L. Griscom, C. Legallais, and E. Leclerc, Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity, Toxicology in Vitro, vol.21, issue.4, pp.535-544, 2007.
DOI : 10.1016/j.tiv.2006.11.004
URL : https://hal.archives-ouvertes.fr/hal-00172268

J. Prot, C. Aninat, L. Griscom, F. Razan, C. Brochot et al., Improvement of HepG2/C3a cell functions in a microfluidic biochip, Biotechnology and Bioengineering, vol.2, issue.7, pp.1704-1715, 2011.
DOI : 10.1002/bit.23104
URL : https://hal.archives-ouvertes.fr/hal-00740224

R. Huang, A. Wallqvist, and D. Covell, Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen, Genomics, vol.87, issue.3, pp.315-328, 2006.
DOI : 10.1016/j.ygeno.2005.11.011

J. Castell, R. Jover, C. Martinez-jimenez, and M. Gomez-lechon, Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies, Expert Opinion on Drug Metabolism & Toxicology, vol.54, issue.2, pp.183-212, 2006.
DOI : 10.1016/j.ab.2005.06.010

C. Torre, C. Perret, and S. Colnot, Transcription dynamics in a physiological process: ??-Catenin signaling directs liver metabolic zonation, The International Journal of Biochemistry & Cell Biology, vol.43, issue.2, pp.271-278, 2011.
DOI : 10.1016/j.biocel.2009.11.004

S. Fajans, G. Bell, and K. Polonsky, Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young, New England Journal of Medicine, vol.345, issue.13, pp.345971-980, 2001.
DOI : 10.1056/NEJMra002168

G. Murray, P. Paterson, R. Weaver, S. Ewen, W. Melvin et al., The expression of cytochrome P-450, epoxide hydrolase, and glutathione s-transferase in hepatocellular carcinoma, Cancer, vol.869, issue.1, pp.36-43, 1993.
DOI : 10.1002/1097-0142(19930101)71:1<36::AID-CNCR2820710107>3.0.CO;2-J

S. Rendic and F. Guengerich, Update Information on Drug Metabolism Systems&#x2014; 2009, Part II. Summary of Information on the Effects of Diseases and Environmental Factors on Human Cytochrome P450 (CYP) Enzymes and Transporters, Current Drug Metabolism, vol.11, issue.1, pp.4-84, 2010.
DOI : 10.2174/138920010791110917

J. Lamba, X. Chen, L. Lan, J. Kim, W. Wang et al., Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans, Pharmacogenetics and Genomics, vol.16, issue.6, pp.16415-427, 2006.
DOI : 10.1097/01.fpc.0000194421.35641.70

A. Braeuning, R. Sanna, J. Huelsken, and M. Schwarz, Inducibility of Drug-Metabolizing Enzymes by Xenobiotics in Mice with Liver-Specific Knockout of Ctnnb1, Drug Metabolism and Disposition, vol.37, issue.5, pp.1138-1145, 2009.
DOI : 10.1124/dmd.108.026179

R. Bars and C. Elcombe, Dose-dependent acinar induction of cytochromes P450 in rat liver Evidence for a differential mechanism of induction of P450IA1 by beta-naphthoflavone and dioxin, Biochem J, issue.2, pp.277577-580, 1991.

T. Oinonen, S. Saarikoski, K. Husgafvel-pursiainen, A. Hirvonen, and K. Lindros, Pretranslational induction of cytochrome P4501A enzymes by betanaphthoflavone and 3-methylcholanthrene occurs in different liver zones, Biochem Pharmacol, issue.12, pp.482189-2197, 1994.

P. Fritz, E. Behrle, P. Beaune, M. Eichelbaum, and H. Kroemer, Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase, Histochemistry, issue.6, pp.99443-451, 1993.

F. Garcia-alcalde, F. Garcia-lopez, J. Dopazo, and A. Conesa, Paintomics: a web based tool for the joint visualization of transcriptomics and metabolomics data, Bioinformatics, vol.27, issue.1, pp.137-139, 2011.
DOI : 10.1093/bioinformatics/btq594

K. Huang, J. Zhang, L. Han, Y. You, T. Jiang et al., MicroRNA roles in beta-catenin pathway, Molecular Cancer, vol.9, issue.1, p.252, 2010.
DOI : 10.1186/1476-4598-9-252

A. Braeuning, Regulation of Cytochrome P450 Expression by Ras- and &#946;-Catenin-Dependent Signaling, Current Drug Metabolism, vol.10, issue.2, pp.138-158, 2009.
DOI : 10.2174/138920009787522160

D. Haussinger, Liver Glutamine Metabolism, Journal of Parenteral and Enteral Nutrition, vol.14, issue.4 Suppl, pp.56-62, 1990.
DOI : 10.1177/014860719001400405

R. Baudoin, L. Griscom, J. Prot, C. Legallais, and E. Leclerc, Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor, Biochemical Engineering Journal, vol.53, issue.2, pp.172-181, 2011.
DOI : 10.1016/j.bej.2010.10.007
URL : https://hal.archives-ouvertes.fr/hal-00592171

B. Henderson, Nuclear-cytoplasmic shuttling of APC regulates betacatenin subcellular localization and turnover, Nature Cell Biology, vol.2, issue.9, pp.653-660, 2000.
DOI : 10.1038/35023605

T. Goasduff and A. Cederbaum, CYP2E1 Degradation by in Vitro Reconstituted Systems: Role of the Molecular Chaperone hsp90, Archives of Biochemistry and Biophysics, vol.379, issue.2, pp.321-330, 2000.
DOI : 10.1006/abbi.2000.1870

B. He, X. Qiu, P. Li, L. Wang, Q. Lv et al., HCCNet: an integrated network database of hepatocellular carcinoma, Cell Research, vol.20, issue.6, pp.732-734, 2010.
DOI : 10.1007/s00432-007-0218-9

G. Levkowitz, H. Waterman, S. Ettenberg, M. Katz, A. Tsygankov et al., Ubiquitin Ligase Activity and Tyrosine Phosphorylation Underlie Suppression of Growth Factor Signaling by c-Cbl/Sli-1, Molecular Cell, vol.4, issue.6, pp.1029-1040, 1999.
DOI : 10.1016/S1097-2765(00)80231-2

A. Dixit and G. Verkhivker, Hierarchical Modeling of Activation Mechanisms in the ABL and EGFR Kinase Domains: Thermodynamic and Mechanistic Catalysts of Kinase Activation by Cancer Mutations, PLoS Computational Biology, vol.222, issue.8, p.1000487, 2009.
DOI : 10.1371/journal.pcbi.1000487.s011

S. Cheng and M. Niv, Molecular Dynamics Simulations and Elastic Network Analysis of Protein Kinase B (Akt/PKB) Inactivation, Journal of Chemical Information and Modeling, vol.50, issue.9, pp.1602-1610, 2010.
DOI : 10.1021/ci100076j

S. Miyake, M. Lupher, . Jr, B. Druker, and H. Band, The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha, Proc Natl Acad Sci, issue.14, pp.957927-7932, 1998.

L. Attisano and J. Wrana, Signal Transduction by the TGF-beta Superfamily, Science, vol.296, issue.5573, pp.1646-1647, 2002.
DOI : 10.1126/science.1071809

R. Gebhardt and A. Hovhannisyan, Organ patterning in the adult stage: The role of Wnt/??-catenin signaling in liver zonation and beyond, Developmental Dynamics, vol.281, issue.1, pp.45-55, 2010.
DOI : 10.1002/dvdy.22041

D. Mavri-damelin, S. Eaton, L. Damelin, M. Rees, H. Hodgson et al., Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2, The International Journal of Biochemistry & Cell Biology, vol.39, issue.3, pp.555-564, 2007.
DOI : 10.1016/j.biocel.2006.10.007

J. Zhang, P. Yang, and N. Gray, Targeting cancer with small molecule kinase inhibitors, Nature Reviews Cancer, vol.62, issue.1, pp.28-39, 2009.
DOI : 10.1016/S0092-8674(03)00194-6

. Cheng, Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditions, BMC Genomics, vol.13, issue.1, p.54, 2012.
DOI : 10.1186/1471-2164-13-54
URL : https://hal.archives-ouvertes.fr/ineris-00961774